Effect of cisapride on gastric dysrhythmia and emptying of indigestible solids in type-II diabetic patients

Scand J Gastroenterol. 1998 Jun;33(6):600-4. doi: 10.1080/00365529850171864.

Abstract

Background: Abnormal gastric slow-wave frequencies have been observed in diabetic gastroparesis. To evaluate the effect of cisapride on gastric dysrhythmia and emptying of indigestible solids, 20 type-II diabetic patients with symptoms suggestive of gastroparesis were enrolled in this study.

Methods: Cutaneous electrogastrography, gastric emptying of radiopaque markers, and evaluation of upper gastrointestinal symptoms were performed before and after administration of an 8-week course of cisapride.

Results: The fasting-state percentages of dominant frequency in normal and tachygastric ranges improved significantly after an 8-week course of cisapride treatment (P < 0.01 and P < 0.05, respectively). The post-meal percentages of dominant frequency in the tachygastric range also improved significantly after cisapride treatment (P < 0.05). The upper gastrointestinal symptoms score decreased significantly, and gastric emptying of radiopaque markers also increased significantly after 8 weeks of cisapride treatment (P < 0.01).

Conclusions: In conclusion, this study showed that cisapride can improve gastric dysrhythmia during both fasting and post-meal phases in patients with diabetic gastroparesis. In addition, upper GI symptoms and gastric emptying of indigestible solids may also show significant improvement after 8 weeks of cisapride treatment.

Publication types

  • Clinical Trial

MeSH terms

  • Blood Glucose / analysis
  • Cisapride
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Female
  • Gastric Emptying / drug effects*
  • Gastrointestinal Agents / therapeutic use*
  • Gastrointestinal Motility / drug effects
  • Gastroparesis / drug therapy*
  • Gastroparesis / etiology
  • Gastroparesis / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Piperidines / therapeutic use*

Substances

  • Blood Glucose
  • Gastrointestinal Agents
  • Piperidines
  • Cisapride